Literature DB >> 3579720

Hereditary hyperlipidemia in the rabbit due to overproduction of lipoproteins. I. Biochemical studies.

A La Ville, P R Turner, R M Pittilo, S Martini, C B Marenah, P M Rowles, G Morris, G A Thomson, N Woolf, B Lewis.   

Abstract

An inherited metabolic disorder in a strain of New Zealand White rabbits, characterized by marked hypercholesterolemia (394 +/- 100 mg/dl), with moderately elevated or normal triglyceride levels is described. Low density lipoprotein (LDL), intermediate density lipoprotein (IDL) and very low density lipoprotein (VLDL) cholesterol levels were increased. VLDL and IDL, and to a lesser extent LDL, had increased free cholesterol and esterified cholesterol content, and triglyceride content was reduced. Kinetic studies with 131I and 125I-labelled rabbit lipoproteins showed a marked increase in production rates of VLDL apo B and LDL apo B. LDL cholesterol levels were directly related to LDL apo B production rate (r = 0.938, p less than 0.001). Both in hypercholesterolemic and normal rabbits injected with labelled VLDL, the specific activity-time curves of VLDL apo B and LDL apo B did not intersect, indicating that LDL apo B was in part derived from sources other than VLDL. No defect was demonstrated in receptor-mediated catabolism of LDL by cultured skin fibroblasts from hyperlipidemic animals. The fractional catabolic rate of LDL apo B was subnormal, but increased when the expanded LDL apo B pool size was reduced by exchange transfusion; the low fractional catabolism may therefore be attributable, at least in part, to saturation of LDL receptors consequent upon the increased pool size of LDL. The hyperlipidemia in this strain of rabbits may be unique in that the underlying mechanism appears to be overproduction of VLDL and LDL.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3579720     DOI: 10.1161/01.atv.7.2.105

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  7 in total

Review 1.  IDL, VLDL, chylomicrons and atherosclerosis.

Authors:  B G Nordestgaard; A Tybjaerg-Hansen
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

Review 2.  Interaction of lipoproteins with the artery wall.

Authors:  N Woolf
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 3.  Plasma lipid concentrations: the concept of "normality" and its implications for detection of high cardiovascular risk.

Authors:  B Lewis
Journal:  J Clin Pathol       Date:  1987-09       Impact factor: 3.411

4.  A genetic model for control of hypertriglyceridemia and apolipoprotein B levels in the Johns Hopkins colony of St. Thomas Hospital rabbits.

Authors:  T H Beaty; V L Prenger; D G Virgil; B Lewis; P O Kwiterovich; P S Bachorik
Journal:  Genetics       Date:  1992-12       Impact factor: 4.562

Review 5.  The transgenic rabbit as model for human diseases and as a source of biologically active recombinant proteins.

Authors:  Zs Bosze; L Hiripi; J W Carnwath; H Niemann
Journal:  Transgenic Res       Date:  2003-10       Impact factor: 2.788

6.  Pathologic findings in rabbit models of hereditary hypertriglyceridemia and hereditary postprandial hypertriglyceridemia.

Authors:  Yoko Mitsuguchi; Tsunekata Ito; Kazuo Ohwada
Journal:  Comp Med       Date:  2008-10       Impact factor: 0.982

Review 7.  Genetically Modified Rabbits for Cardiovascular Research.

Authors:  Jianglin Fan; Yanli Wang; Y Eugene Chen
Journal:  Front Genet       Date:  2021-02-02       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.